The purpose of this research was to formulate modified liquisolid compacts (MLSC) of RLX for improved dissolution in immediate-release tablet formulations.
Regulators have exaggerated expectations for simulated media fills.
SCHOTT has run a series of line tests to prove the efficacy and efficiency of its modular EVERIC product concepts against vial breakage. The results show a great increase in glass strength. | Sponsored Content
LabSolutions Insight Biologics, a complete workflow from data acquisition to analysis and reporting! Your dedicated workspace for oligonucleotide characterisation.
Synthetic biology can help researchers circumvent the challenges of traditional methods of antibody generation.
Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.
Consider current large-scale practices for oligonucleotide synthesis as a basis for improving commercial-scale platform strategies.
Consider current large-scale practices for oligonucleotide synthesis as a basis for improving commercial-scale platform strategies.
Consider current large-scale practices for oligonucleotide synthesis as a basis for improving commercial-scale platform strategies.
CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.
Complex protein structures pose analytical challenges that can be addressed by advanced mass spectrometry technologies and workflows, which can be used to comprehensively characterize them.
This paper discusses what causes cross-linking, how cross-linking is addressed with addition of enzymes, and consideration for occasional high results that can be obtained during release testing.
Can the pharmaceutical industry embrace the goals of Quality 4.0?
Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost.
The author examines the challenges that arise in ordering, storing, and using gas supplies for the pharmaceutical laboratory, and suggests solutions to these difficulties.
*Thursday, May 6, 2021 at 2pm EDT | 1pm CDT | 11am PDT* Learn how artificial intelligence can be used to investigate corrective and preventive actions, pinpoint the root cause of the most common complaints, tell if training is effective, and identify the combination of materials and workers to increase production. *On Demand Until May 6, 2022*
The first-of-its-kind MALDImini-1 digital ion trap mass spectrometer targets comprehensive structural analyses applications. It is the only device capable of MALDI-MSn on the compact footprint of an A3-sized paper.
Myths and misunderstanding abound when it comes to microbiology. When it comes to cleanroom and pharmaceutical microbiology, some “myths” have become engrained and even endorsed by regulatory bodies. The authors use logic and sound science to dispel some Microbiological Myths related to Disinfectant Cleaning of Controlled Environments.
Myths and misunderstanding abound when it comes to microbiology. When it comes to cleanroom and pharmaceutical microbiology, some “myths” have become engrained and even endorsed by regulatory bodies. The authors use logic and sound science to dispel some Microbiological Myths related to Disinfectant Cleaning of Controlled Environments.
Tablet press design innovation has traditionally centered on large-scale production equipment, however, there is increasing focus on the smaller-scale, mid-range models that must have the capability to support product development, scale-up, tech transfer, clinical batch manufacturing, small and medium batch production, and continuous manufacturing applications. This range of capabilities demands unique features and design flexibility.
President and CEO of Pharmaceutics International, Inc. (Pii), John Fowler, reacts to the agility and flexibility needed to support the development and manufacture of today's complex biotherapeutics.
This whitepaper describes the microencapsulation process of coacervation using both aqueous and solvent pathways, and the many benefits for drug developers.
Adam Covitt, President of Federal Equipment Company, discusses how the company enables CDMO successes with its Techceuticals and PharmParts business brands.
The authors present a simple-to-use Microsoft Excel-based statistical tool that uses cumulative sum techniques to aid retrospective understanding of data trends.
The authors present a simple-to-use Microsoft Excel-based statistical tool that uses cumulative sum techniques to aid retrospective understanding of data trends.
Webinar Date/Time: Tuesday, February 28th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET